Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
New research has identified hundreds of proteins that can lead to the development of metabolic diseases, such as type 2 diabetes mellitus, and therefore have treatment potential.
Read Full NewsUltragenyx seeks FDA accelerated approval for UX111 gene therapy in Sanfilippo syndrome, citing neurologic benefit and the use of cerebral spinal fluid heparan sulfate data.
Here's some of what is coming soon to NeurologyLive® this week.
AGNOS trial showed that monthly treatment with ofatumumab lowered NfL and GFAP in patients with early RRMS, signaling reduced nerve damage and bolstering first-line treatment potential.
Pediatric neurologist Charuta Joshi, MD, discussed global disparities in epilepsy for children and adolescents amid International Epilepsy Day, highlighting opportunities for education, stigma reduction, and improved care access.
The FDA issued a CRL for gene therapy RGX-121 in Hunter syndrome, citing trial design and biomarker doubts; Regenxbio seeks a meeting with the agency and resubmission.
In this interview, Siegel highlights key points presented in his Maui Derm 2026 talk, 'How To Maximize Your Billing Effectiveness in the Era of Dwindling Reimbursements and ICD-10.'
New Phase 3 Findings Support Ameluz-PDT for Patients with Actinic Keratosis
1.
ALK-positive lung cancer trial results show unprecedented progression-free survival.
2.
Breast cancer: A new target to eliminate dormant cells before they wake
3.
Pickleball program boosts health and wellness for cancer survivors, study finds
4.
Having a tattoo could increase your risk of developing lymphoma.
5.
Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.
1.
Beta-2 Microglobulin: Function, Role in Disease & Clinical Significance Explained
2.
The Essential Guide to Understanding Fibrinogen and Its Role in Blood Clotting
3.
The benefits and risks of taking fludrocortisone for adrenal insufficiency
4.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
5.
Unveiling the Mystery of Epstein-Barr Virus: What We Know So Far
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
2.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
4.
Efficient Management of First line ALK-rearranged NSCLC - Part II
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge